HBV reactivation and its management in HBV-related HCC patients undergoing HAIC-TKI-ICI therapy: A multicenter study. [PDF]
Liu J +12 more
europepmc +1 more source
Current status and challenges of therapeutic targets, novel drugs and delivery systems for hepatitis B: how far to our goal? [PDF]
Liao Y, Lv F, Zhou M, Shen J, Quan T.
europepmc +1 more source
QuEChERS and UPLC-MS/MS-Based Quantification of Human Plasma of Eight Nucleoside Reverse Transcriptase Inhibitors and Platinum Anticancer Drugs for Hepatocellular Carcinoma. [PDF]
Liu Y +5 more
europepmc +1 more source
Dades epidemiològiques, clíniques i tractament de pacients amb infecció crònica pel virus hepatitis b en l'àrea barcelonès nord i maresme [PDF]
Morillas Cunill, Rosa Ma. +4 more
core
Comparative impact of antiviral therapies on postoperative recurrence risk in patients with hepatitis B virus-related hepatocellular carcinoma. [PDF]
Liu HM +4 more
europepmc +1 more source
Duration of Nucleos(t)ide Analogue Treatments in Patients With Chronic Hepatitis B Virus Infection in the United States. [PDF]
Anderson S +9 more
europepmc +1 more source
VALIDATION OF THE PAGE-B SCORE AS A PROGNOSIS OF DEVELOPMENT TO HEPATOCELLULAR CARCINOMA (HCC) IN CHRONIC HEPATITIS B, IN THE BRAZILIAN POPULATION. [PDF]
Silva ILV +9 more
europepmc +1 more source
Comparison of efficacy and safety of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate treatment in patients with high viral load of hepatitis B virus. [PDF]
Zhang C +6 more
europepmc +1 more source
Variation in Nucleos(t)ide Analogue Use in Medicare Part D Throughout the United States. [PDF]
Congly SE +5 more
europepmc +1 more source
Tenofovir disoproxil fumarate: safe and effective option for managing high-viral-load chronic hepatitis B. [PDF]
Song W, Bao J.
europepmc +1 more source

